Advertisement CLX Medical signs distribution agreement with Leti Laboratories - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CLX Medical signs distribution agreement with Leti Laboratories

CLX Medical has reached an agreement with Leti Laboratories, a Barcelona-based biopharmaceutical company, to serve as the sole importer of CLX's subsidiary products into the European market.

Leti Laboratories will provide product support and product packaging control, coordinate sales to other European distributors, distribute the company’s products in Spain and Portugal, act as the registered EU representative for CE marked products, serve as the one point of entry for CLX products into Europe, and assist with the development and implementation of pricing structures.

The representatives of CLX Medical and Leti Laboratories agreed to terms that will be included in a letter of intent between the two companies. Some of the initial work that will be undertaken by Leti on behalf of CLX’s subsidiary products includes market research and a plan for distribution in the European market.

Vera Leonard, CEO of CLX Medical, said: “Our association is expected to provide a number of distinct advantages for CLX as we pursue widespread distribution for our subsidiary products and additional medical diagnostic tests that we may choose to acquire or license. Leti will be an excellent partner for CLX as we seek to expand distribution of our products in the European market.”